newsfilter
← Latest News
GlobeNewswire·

Antares Pharma Receives FDA Fast Track Designation for ATRS-1902 for Adrenal Crisis Rescue

EWING, N.J., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) (the "Company"), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration ("FDA") has granted Fast Track designation for ATRS-1902 f